Results 231 to 240 of about 656,371 (370)

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification [PDF]

, 2001
Jesús F. San Miguel, María‐Belén Vidriales, C López-Berges, Joaquín Diaz‐Mediavilla, Norma C. Gutiérrez, Consuelo del Cañizo, Fernando Ramos, María José Calmuntia, José J. Pérez, Marcos González, Alberto Órfão   +10 more
openalex   +1 more source

Minimal residual disease in ALL [PDF]

Nature Reviews Clinical Oncology, 2010
openaire   +3 more sources

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

Molecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben‐Moshe, Anya Pavlovsky, Rinat Bernstein‐Molho, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal‐Yam   +14 more
wiley   +1 more source

Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia [PDF]

, 2001
Joseph G. Jurcic, Stephen D. Nimer, David A. Scheinberg, Tony DeBlasio, Raymond P. Warrell, Wilson H. Miller   +5 more
openalex   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Molecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Conrad Droste, Alicia Landeira‐Viñuela, Miguel Alcoceba, Helena Fidalgo‐Gómez, Sara Misiego‐Herrero, Almudena Navarro‐Bailón, Mónica Baile, José M. Bastida, Jose Manuel Sanchez‐Santos, Rafael Góngora, Julia Almeida, Marcos Gonzalez‐Diaz, Alberto Orfao, Javier De Las Rivas, Manuel Fuentes   +17 more
wiley   +1 more source

The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia [PDF]

, 2001
Mehmet Uzunel, Jonas Mattsson, Marie Jaksch, Mats Remberger, Olle Ringdén   +4 more
openalex   +1 more source

Minimal Residual Disease in Indolent Lymphomas: A Critical Assessment [PDF]

, 2018
Ferrante, M., Ferrero, S., Genuardi, E., Grimaldi, D., Ladetto, M.   +4 more
core   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source

Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia [PDF]

, 2001
Maiko Matsushita, Hideyuki Ikeda, Masahiro Kizaki, Shinichiro Okamoto, Masahiro Ogasawara, Yasuo Ikeda, Yutaka Kawakami   +6 more
openalex   +1 more source

Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors

Molecular Diagnosis & Therapy, 2021
Kevin Chen, M. Shields, P. Chauhan, R. Ramirez, P. Harris, M. Reimers, J. Zevallos, A. Davis, B. Pellini, A. Chaudhuri   +9 more
semanticscholar   +1 more source